Fintel reports that on March 12, 2025, Ladenburg Thalmann downgraded their outlook for Zynex (NasdaqGS:ZYXI) from Buy to ...

Germany’s Heidelberg Pharma (FSE: HPHA) has modified its royalty financing agreement with HealthCare Royalty (HCRx), securing an additional $20 million upfront payment. The amendment extends the ...

Ladenburg, Germany, 13 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today ...

Q4 2024 Earnings Call Transcript March 12, 2025 Operator: Welcome to the Ondas Holdings Inc., Fourth Quarter and Full Year ...

EVANSTON, Ill., March 12, 2025 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ: FDUS) (“Fidus” or the “Company”) today announced that it has priced an underwritten public offering of $100 ...

Creative Realities (NASDAQ:CREX – Get Free Report) is expected to announce its earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of ($0 ...

ContractHeidelberg Pharma Amends Royalty Financing with HealthCare Royalty 13-March-2025 / 00:31 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, ...

Eric Brock; Chairman of the Board, President, Chief Executive Officer; Ondas Holdings Inc Neil Laird; Interim Chief Financial Officer, Treasurer and Secretary of the Company; Ondas Holdings Inc Markus ...

UroGen Pharma (NASDAQ:URGN – Get Free Report) had its price target decreased by equities researchers at HC Wainwright from ...

Lifetime Brands Inc (LCUT) is expected to report $0.40 for 4Q. Lipocine Inc (LPCN) is expected to report $-0.40 for 4Q. Medical Facilities Corp (DR.T) is expected to report $0.41 for 4Q. Mondee ...

Q4 2024 Results Conference Call March 12, 2025 5:30 PM ETCompany ParticipantsDan Goldberger - CEO & DirectorJoshua Lev ...